Nurix Therapeutics, Inc.
NRIX · NASDAQ
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$194 | -$144 | -$180 | -$117 |
| Dep. & Amort. | $16 | $14 | $11 | $6 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34 | $34 | $28 | $16 |
| Change in WC | -$18 | $20 | -$19 | $9 |
| Other Non-Cash | -$11 | -$5 | $1 | $2 |
| Operating Cash Flow | -$173 | -$81 | -$160 | -$84 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$8 | -$12 | -$6 |
| Net Acquisitions | $0 | $0 | -$39 | $103 |
| Inv. Purchases | -$708 | -$246 | -$239 | -$348 |
| Inv. Sales/Matur. | $460 | $323 | $279 | $246 |
| Other Inv. Act. | $0 | $0 | $39 | -$103 |
| Investing Cash Flow | -$258 | $68 | $27 | -$108 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $478 | $3 | $19 | $150 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $0 | $98 | $4 |
| Financing Cash Flow | $486 | $3 | $117 | $154 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $55 | -$10 | -$15 | -$39 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56 | $65 | $81 | $120 |
| End Cash | $111 | $56 | $65 | $81 |
| Free Cash Flow | -$182 | -$90 | -$172 | -$90 |